| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.50e-07 | 11 | 24 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.23e-06 | 18 | 24 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.46e-06 | 19 | 24 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.31e-06 | 22 | 24 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.88e-05 | 50 | 24 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.35e-05 | 65 | 24 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.35e-05 | 65 | 24 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.05e-04 | 77 | 24 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.46e-04 | 86 | 24 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.29e-04 | 100 | 24 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.49e-04 | 103 | 24 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.40e-04 | 125 | 24 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.64e-04 | 151 | 24 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.09e-03 | 171 | 24 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.55e-03 | 193 | 24 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.64e-03 | 197 | 24 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.12e-03 | 57 | 24 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.35e-03 | 60 | 24 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.64e-03 | 75 | 24 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.23e-03 | 334 | 24 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.15e-02 | 749 | 24 | 4 | GO:0005509 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 4.20e-06 | 30 | 22 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 6.74e-06 | 35 | 22 | 3 | GO:0007214 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 6.50e-05 | 74 | 22 | 3 | GO:0051932 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.23e-04 | 112 | 22 | 3 | GO:1902476 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion mediated by integrin | 2.71e-04 | 23 | 22 | 2 | GO:0033630 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.30e-04 | 128 | 22 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.77e-04 | 134 | 22 | 3 | GO:0098661 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.11e-06 | 19 | 23 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.53e-06 | 21 | 23 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | dendrite membrane | 3.10e-05 | 56 | 23 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.27e-05 | 57 | 23 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | neuron projection membrane | 9.74e-05 | 82 | 23 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.53e-03 | 210 | 23 | 3 | GO:0031256 | |
| GeneOntologyCellularComponent | dendrite | 2.09e-03 | 858 | 23 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.11e-03 | 860 | 23 | 5 | GO:0097447 | |
| GeneOntologyCellularComponent | receptor complex | 3.43e-03 | 581 | 23 | 4 | GO:0043235 | |
| Domain | GABBAg_rcpt | 1.86e-09 | 3 | 24 | 3 | IPR005437 | |
| Domain | ARF7EP_C | 1.58e-06 | 2 | 24 | 2 | IPR029264 | |
| Domain | ARF7EP_C | 1.58e-06 | 2 | 24 | 2 | PF14949 | |
| Domain | GABAA/Glycine_rcpt | 3.25e-06 | 23 | 24 | 3 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.55e-05 | 45 | 24 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 2.73e-05 | 46 | 24 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 2.91e-05 | 47 | 24 | 3 | PF02931 | |
| Domain | Neur_channel | 2.91e-05 | 47 | 24 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.91e-05 | 47 | 24 | 3 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 2.91e-05 | 47 | 24 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 2.91e-05 | 47 | 24 | 3 | IPR006029 | |
| Domain | - | 2.91e-05 | 47 | 24 | 3 | 2.70.170.10 | |
| Domain | EGF_extracell | 2.68e-03 | 60 | 24 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.68e-03 | 60 | 24 | 2 | PF07974 | |
| Domain | zf-B_box | 3.83e-03 | 72 | 24 | 2 | PF00643 | |
| Domain | ZF_BBOX | 4.70e-03 | 80 | 24 | 2 | PS50119 | |
| Domain | Znf_B-box | 4.82e-03 | 81 | 24 | 2 | IPR000315 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.57e-06 | 31 | 11 | 3 | M39369 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 2.94e-06 | 38 | 11 | 3 | M39854 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 7.09e-05 | 109 | 11 | 3 | M39542 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 9.21e-05 | 119 | 11 | 3 | M48309 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 8.93e-04 | 58 | 11 | 2 | M544 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 9.56e-04 | 60 | 11 | 2 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 9.56e-04 | 60 | 11 | 2 | MM15708 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.05e-03 | 272 | 11 | 3 | M13380 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 19019179 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 11948245 | ||
| Pubmed | 3.45e-08 | 10 | 24 | 3 | 20583128 | ||
| Pubmed | 4.75e-08 | 11 | 24 | 3 | 39137998 | ||
| Pubmed | 2.34e-07 | 18 | 24 | 3 | 18985723 | ||
| Pubmed | 2.34e-07 | 18 | 24 | 3 | 19078961 | ||
| Pubmed | Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo. | 4.56e-07 | 2 | 24 | 2 | 10536013 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 1321425 | ||
| Pubmed | GABAA receptor α and γ subunits shape synaptic currents via different mechanisms. | 4.56e-07 | 2 | 24 | 2 | 24425869 | |
| Pubmed | Trans-ethnic meta-analysis of genome-wide association studies for Hirschsprung disease. | 1.37e-06 | 3 | 24 | 2 | 27702942 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20361209 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 25666438 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20579975 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 27203398 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 34006365 | ||
| Pubmed | Gephyrin plays a key role in BDNF-dependent regulation of amygdala surface GABAARs. | 2.74e-06 | 4 | 24 | 2 | 24096136 | |
| Pubmed | Prostaglandin E2 attenuates preoptic expression of GABAA receptors via EP3 receptors. | 2.74e-06 | 4 | 24 | 2 | 18292084 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 12574411 | ||
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 9682826 | ||
| Pubmed | RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression. | 6.83e-06 | 6 | 24 | 2 | 17049487 | |
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 7560270 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 1315307 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 17362911 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 16080114 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 9.56e-06 | 7 | 24 | 2 | 10449790 | |
| Pubmed | Visualizing mechanosensory endings of TrkC-expressing neurons in HS3ST-2-hPLAP mice. | 1.27e-05 | 8 | 24 | 2 | 18839409 | |
| Pubmed | 1.64e-05 | 9 | 24 | 2 | 24752460 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 2.05e-05 | 10 | 24 | 2 | 21789198 | |
| Pubmed | 2.38e-05 | 81 | 24 | 3 | 22723691 | ||
| Pubmed | 3.00e-05 | 12 | 24 | 2 | 25839327 | ||
| Pubmed | 4.13e-05 | 14 | 24 | 2 | 22768092 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 1.25e-04 | 24 | 24 | 2 | 15869472 | |
| Pubmed | 1.71e-04 | 28 | 24 | 2 | 17951031 | ||
| Pubmed | 1.81e-04 | 418 | 24 | 4 | 34709266 | ||
| Pubmed | 2.10e-04 | 31 | 24 | 2 | 19736351 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 2.63e-04 | 182 | 24 | 3 | 20468064 | |
| Pubmed | 3.50e-04 | 40 | 24 | 2 | 36843585 | ||
| Pubmed | 4.84e-04 | 47 | 24 | 2 | 35462405 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.49e-04 | 248 | 24 | 3 | 24006456 | |
| Interaction | GABRG1 interactions | 2.84e-05 | 7 | 24 | 2 | int:GABRG1 | |
| Interaction | SHANK2 interactions | 3.74e-05 | 55 | 24 | 3 | int:SHANK2 | |
| Cytoband | 3q26.1 | 9.82e-05 | 28 | 24 | 2 | 3q26.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q26 | 5.68e-03 | 216 | 24 | 2 | chr3q26 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 7.95e-07 | 19 | 18 | 3 | 563 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.84e-03 | 718 | 18 | 4 | 28 | |
| GeneFamily | Immunoglobulin like domain containing | 1.55e-02 | 193 | 18 | 2 | 594 | |
| ToppCell | Control-Lymphoid_T/NK-dn_T|Control / Disease group, lineage and cell class | 4.26e-05 | 127 | 24 | 3 | 58f47cb079c596a9119d8bf158c1681b28360ac3 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 4.46e-05 | 129 | 24 | 3 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.88e-05 | 133 | 24 | 3 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 169 | 24 | 3 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 169 | 24 | 3 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 171 | 24 | 3 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 172 | 24 | 3 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 175 | 24 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 176 | 24 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 177 | 24 | 3 | 0721199be6d29777dc0f47845aafd027fd376a32 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 178 | 24 | 3 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 179 | 24 | 3 | 53e700494d251ec5649b2dea5fc7d5aeeeed572b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 179 | 24 | 3 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 180 | 24 | 3 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 180 | 24 | 3 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 180 | 24 | 3 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 187 | 24 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-04 | 190 | 24 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 191 | 24 | 3 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 191 | 24 | 3 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 191 | 24 | 3 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 193 | 24 | 3 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.49e-04 | 194 | 24 | 3 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.49e-04 | 194 | 24 | 3 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-04 | 194 | 24 | 3 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 196 | 24 | 3 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 197 | 24 | 3 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 198 | 24 | 3 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 199 | 24 | 3 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | a95aa72387c9558e0316898eaa9df4de8932af1b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 8444ae3c10b1152dec67ca812e6c417cc3b9cf89 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 193c42c31a366a60d80c4c1fc6a1592a5b01a3ad | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 7c780e995a5fc3793080da61b6bf7a12880e9df8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)----L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | d0b31dc5eedc0635c0d7ceabaa6202386cf2a4a4 | |
| Computational | Neighborhood of RBM8A | 9.97e-05 | 85 | 12 | 3 | MORF_RBM8A | |
| Computational | Ion channels. | 3.95e-04 | 27 | 12 | 2 | MODULE_214 | |
| Drug | Bu-1014 | 1.69e-07 | 11 | 24 | 3 | CID015942721 | |
| Drug | fosazepam | 1.69e-07 | 11 | 24 | 3 | CID000037114 | |
| Drug | Zapizolam | 1.69e-07 | 11 | 24 | 3 | CID000068832 | |
| Drug | C19H18ClN3O | 1.69e-07 | 11 | 24 | 3 | CID000027452 | |
| Drug | flutoprazepam | 1.69e-07 | 11 | 24 | 3 | CID000003400 | |
| Drug | Reclazepam | 1.69e-07 | 11 | 24 | 3 | CID003052777 | |
| Drug | iclazepam | 1.69e-07 | 11 | 24 | 3 | CID000068777 | |
| Drug | Arfendazam | 1.69e-07 | 11 | 24 | 3 | CID000065803 | |
| Drug | menitrazepam | 1.69e-07 | 11 | 24 | 3 | CID000189875 | |
| Drug | Serin hydrazid | 1.69e-07 | 11 | 24 | 3 | CID000041637 | |
| Drug | sulazepam | 1.69e-07 | 11 | 24 | 3 | CID000017931 | |
| Drug | elfazepam | 1.69e-07 | 11 | 24 | 3 | CID000065445 | |
| Drug | camazepam | 1.69e-07 | 11 | 24 | 3 | CID000037367 | |
| Drug | uldazepam | 1.69e-07 | 11 | 24 | 3 | CID000034274 | |
| Drug | gidazepam | 1.69e-07 | 11 | 24 | 3 | CID000121919 | |
| Drug | triflubazam | 1.69e-07 | 11 | 24 | 3 | CID000031157 | |
| Drug | fletazepam | 1.69e-07 | 11 | 24 | 3 | CID000036834 | |
| Drug | SB-205384 | 2.25e-07 | 12 | 24 | 3 | CID000197690 | |
| Drug | U-93631 | 2.25e-07 | 12 | 24 | 3 | CID000197626 | |
| Drug | haloxazolam | 2.25e-07 | 12 | 24 | 3 | CID000003563 | |
| Drug | pivoxazepam | 2.25e-07 | 12 | 24 | 3 | CID000068722 | |
| Drug | razobazam | 2.25e-07 | 12 | 24 | 3 | CID000071228 | |
| Drug | doxefazepam | 2.25e-07 | 12 | 24 | 3 | CID000038668 | |
| Drug | cinolazepam | 2.92e-07 | 13 | 24 | 3 | CID003033621 | |
| Drug | AC1MVFYM | 2.92e-07 | 13 | 24 | 3 | CID003707225 | |
| Drug | nerisopam | 2.92e-07 | 13 | 24 | 3 | CID000065875 | |
| Drug | flutazolam | 2.92e-07 | 13 | 24 | 3 | CID000003398 | |
| Drug | alpha IMGBL | 2.92e-07 | 13 | 24 | 3 | CID000131516 | |
| Drug | 4-PIOL | 2.92e-07 | 13 | 24 | 3 | CID000125520 | |
| Drug | Ro 11-3128 | 2.92e-07 | 13 | 24 | 3 | CID000093364 | |
| Drug | metaclazepam | 2.92e-07 | 13 | 24 | 3 | CID000071272 | |
| Drug | Me-lex | 3.72e-07 | 14 | 24 | 3 | CID000004177 | |
| Drug | beta-CCt | 3.72e-07 | 14 | 24 | 3 | CID000124514 | |
| Drug | ethyl loflazepate | 3.72e-07 | 14 | 24 | 3 | CID000003299 | |
| Drug | loprazolam | 4.64e-07 | 15 | 24 | 3 | CID003033860 | |
| Drug | SR 95103 | 4.64e-07 | 15 | 24 | 3 | CID000125958 | |
| Drug | premazepam | 4.64e-07 | 15 | 24 | 3 | CID000072104 | |
| Drug | pinazepam | 4.64e-07 | 15 | 24 | 3 | CID000040391 | |
| Drug | fludiazepam | 4.64e-07 | 15 | 24 | 3 | CID000003369 | |
| Drug | TBOB | 4.64e-07 | 15 | 24 | 3 | CID000114986 | |
| Drug | girisopam | 4.64e-07 | 15 | 24 | 3 | CID000071257 | |
| Drug | P858 | 5.71e-07 | 16 | 24 | 3 | CID000004617 | |
| Drug | tetrazepam | 5.71e-07 | 16 | 24 | 3 | CID000025215 | |
| Drug | Ro 19-4603 | 5.71e-07 | 16 | 24 | 3 | CID000127382 | |
| Drug | nimetazepam | 5.71e-07 | 16 | 24 | 3 | CID000004496 | |
| Drug | dihydroxyaflavinine | 6.93e-07 | 17 | 24 | 3 | CID000156857 | |
| Drug | CL 218,872 | 6.93e-07 | 17 | 24 | 3 | CID000107950 | |
| Drug | enflurane | 7.39e-07 | 68 | 24 | 4 | CID000003226 | |
| Drug | abecarnil | 8.31e-07 | 18 | 24 | 3 | CID000065914 | |
| Drug | cloxazolam | 8.31e-07 | 18 | 24 | 3 | CID000002816 | |
| Drug | clorazepate | 8.31e-07 | 18 | 24 | 3 | CID000002809 | |
| Drug | phenazepam | 8.31e-07 | 18 | 24 | 3 | CID000040113 | |
| Drug | lormetazepam | 8.31e-07 | 18 | 24 | 3 | CID000013314 | |
| Drug | etifoxine | 9.86e-07 | 19 | 24 | 3 | CID000030768 | |
| Drug | ZK 93426 | 9.86e-07 | 19 | 24 | 3 | CID000115210 | |
| Drug | AC1N65YL | 1.16e-06 | 20 | 24 | 3 | CID004229818 | |
| Drug | halazepam | 1.16e-06 | 20 | 24 | 3 | CID000031640 | |
| Drug | Ro 15-4513 | 1.16e-06 | 20 | 24 | 3 | CID000005081 | |
| Drug | EBOB | 1.16e-06 | 20 | 24 | 3 | CID000115223 | |
| Drug | prazepam | 1.35e-06 | 21 | 24 | 3 | CID000004890 | |
| Drug | R 5135 | 1.35e-06 | 21 | 24 | 3 | CID000119544 | |
| Drug | bicuculline methochloride | 1.35e-06 | 21 | 24 | 3 | CID000123659 | |
| Drug | Iomazenil (123I | 1.56e-06 | 22 | 24 | 3 | CID000065959 | |
| Drug | quazepam | 1.56e-06 | 22 | 24 | 3 | CID000004999 | |
| Drug | imidazenil | 1.56e-06 | 22 | 24 | 3 | CID000119194 | |
| Drug | etizolam | 1.56e-06 | 22 | 24 | 3 | CID000003307 | |
| Drug | 6 mEq | 1.56e-06 | 22 | 24 | 3 | CID000126186 | |
| Drug | adinazolam | 1.80e-06 | 23 | 24 | 3 | CID000037632 | |
| Drug | bretazenil | 1.80e-06 | 23 | 24 | 3 | CID000107926 | |
| Drug | zolazepam | 1.80e-06 | 23 | 24 | 3 | CID000035775 | |
| Drug | methohexital | 2.05e-06 | 24 | 24 | 3 | CID000009034 | |
| Drug | gamma-acetylenic GABA | 2.05e-06 | 24 | 24 | 3 | CID000003452 | |
| Drug | medazepam | 2.05e-06 | 24 | 24 | 3 | CID000004041 | |
| Drug | alpidem | 2.05e-06 | 24 | 24 | 3 | CID000054897 | |
| Drug | SL 75102 | 2.05e-06 | 24 | 24 | 3 | CID005751746 | |
| Drug | beta-CCM | 2.05e-06 | 24 | 24 | 3 | CID000107704 | |
| Drug | isonipecotic acid | 2.33e-06 | 25 | 24 | 3 | CID000003773 | |
| Drug | P4-s | 2.33e-06 | 25 | 24 | 3 | CID000004838 | |
| Drug | CCD 1042 | 2.33e-06 | 25 | 24 | 3 | CID000038022 | |
| Drug | beta-CCE | 2.33e-06 | 25 | 24 | 3 | CID000105078 | |
| Drug | SKF97541 | 2.63e-06 | 26 | 24 | 3 | CID000005230 | |
| Drug | V-X-A | 2.63e-06 | 26 | 24 | 3 | CID006369389 | |
| Drug | pitrazepin | 2.96e-06 | 27 | 24 | 3 | CID000146222 | |
| Drug | chlormethiazole | 3.31e-06 | 28 | 24 | 3 | CID000010783 | |
| Drug | mephobarbital | 3.31e-06 | 28 | 24 | 3 | CID000008271 | |
| Drug | tofisopam | 3.69e-06 | 29 | 24 | 3 | CID000005502 | |
| Drug | etazolate | 3.69e-06 | 29 | 24 | 3 | CID000003277 | |
| Drug | clobazam | 3.69e-06 | 29 | 24 | 3 | CID000002789 | |
| Drug | clotiazepam | 3.69e-06 | 29 | 24 | 3 | CID000002811 | |
| Drug | 3-isothujone | 4.10e-06 | 30 | 24 | 3 | CID000011027 | |
| Drug | guvacine | 4.10e-06 | 30 | 24 | 3 | CID000003532 | |
| Drug | allylglycine | 4.10e-06 | 30 | 24 | 3 | CID000014044 | |
| Drug | sevoflurane | 4.23e-06 | 105 | 24 | 4 | CID000005206 | |
| Drug | SKF89976A | 4.54e-06 | 31 | 24 | 3 | CID000092409 | |
| Drug | homotaurine | 5.00e-06 | 32 | 24 | 3 | CID000001646 | |
| Drug | 3-aminopropylphosphinic acid | 5.00e-06 | 32 | 24 | 3 | CID006335948 | |
| Drug | barbiturate | 5.00e-06 | 32 | 24 | 3 | CID000006211 | |
| Drug | CGS 8216 | 5.50e-06 | 33 | 24 | 3 | CID000104916 | |
| Drug | AC1L2FYN | 5.50e-06 | 33 | 24 | 3 | CID000071333 | |
| Drug | amobarbital | 6.03e-06 | 34 | 24 | 3 | CID000002163 | |
| Disease | phosphatidylethanolamine measurement | 3.22e-04 | 173 | 23 | 3 | EFO_0010228 | |
| Disease | Alcoholic Intoxication, Chronic | 1.15e-03 | 268 | 23 | 3 | C0001973 | |
| Disease | age at menopause | 1.62e-03 | 302 | 23 | 3 | EFO_0004704 | |
| Disease | hypertrophic cardiomyopathy | 2.33e-03 | 92 | 23 | 2 | EFO_0000538 | |
| Disease | pancreatic cancer (is_marker_for) | 2.80e-03 | 101 | 23 | 2 | DOID:1793 (is_marker_for) | |
| Disease | S-7-hydroxywarfarin measurement | 3.31e-03 | 110 | 23 | 2 | EFO_0803329 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLCDCLEKNCLGCFY | 96 | P0DKL9 | |
| CLDEDCLGCFYACPA | 211 | Q8N8R7 | |
| LPCLLDADKYFCECC | 256 | Q9Y5A7 | |
| AAADDFLYLECCKCF | 41 | Q6IE37 | |
| TYLCYSFLCCCDDLG | 31 | Q9Y278 | |
| LCLKLYCDCFANGEF | 531 | Q6MZP7 | |
| CKRSGCLKNYCECYE | 601 | Q6MZP7 | |
| IYCCCCRGKDDNTED | 256 | Q99795 | |
| GLCDLYPCCLCDYKL | 66 | Q14990 | |
| LCLDNCIGICKFTDY | 136 | Q6JEL2 | |
| CLEGKDCASFFCCFE | 406 | Q8N1C3 | |
| YECLDGKDCQSFFCC | 406 | Q99928 | |
| YECLDGKDCASFFCC | 406 | P18507 | |
| SFAECAYGDCCKDCR | 451 | Q13443 | |
| CDCCDYSCKNLIDLQ | 286 | Q9BQA5 | |
| RQDCDLINDCCCKHY | 746 | Q8NG08 | |
| TLDPADFFLNCCDCC | 91 | A6NHN0 | |
| CLLDCFHDFCAGCLR | 36 | Q6ZRF8 | |
| EACCELCGLYFENRK | 1396 | O95785 | |
| RCDIYGKACAECCLA | 516 | Q14563 | |
| HCSYLCDEGKDCCDR | 276 | Q4LDE5 | |
| KCYECKECGQAFLCS | 296 | Q9Y2G7 | |
| GYCCLECGDAFALEK | 586 | Q92610 | |
| YGTCNCFPEEEKCFC | 606 | P07949 | |
| CNVCDDFDLCYGCYA | 1846 | O43149 | |
| CLECGEDYCSGCFAK | 146 | A8MT70 |